Your browser doesn't support javascript.
loading
Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Viviani, Simonetta; Mazzocchi, Arabella; Pavoni, Chiara; Taverna, Francesca; Rossi, Andrea; Patti, Caterina; Romano, Alessandra; Trentin, Livio; Sorasio, Roberto; Guidetti, Anna; Gottardi, Daniela; Tarella, Corrado; Cimminiello, Michele; Zanotti, Roberta; Farina, Lucia; Ferreri, Andrés José Maria; Galbiati, Marina; Corradini, Paolo; Gianni, Alessandro Massimo; Gallamini, Andrea; Rambaldi, Alessandro.
Afiliação
  • Viviani S; Department of Hemato-Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Mazzocchi A; Immuno-hematology and Transfusion Medicine Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Pavoni C; Department of Oncology and Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Taverna F; Immuno-hematology and Transfusion Medicine Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rossi A; Department of Oncology and Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
  • Patti C; Division of Hematology 1, Azienda Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
  • Romano A; Department of Medical and Surgery Science, Hematology Unit, University of Catania, Catania, Italy.
  • Trentin L; Department of Hematology, University of Padova, Padova, Italy.
  • Sorasio R; Division of Hematology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
  • Guidetti A; Department of Hemato-Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gottardi D; Division of Hematology, Ospedale Mauriziano Umberto I di Torino, Turin, Italy.
  • Tarella C; Hemato-Oncology Division, European Institute of Oncology IRCCS, Milan, Italy.
  • Cimminiello M; University Department "Scienze della Salute" (DISS), University of Milan, Milan, Italy.
  • Zanotti R; Divisione Universitaria di Ematologia, Ospedale San Carlo, Potenza, Italy.
  • Farina L; Hematology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
  • Ferreri AJM; Department of Hemato-Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Galbiati M; Lymphoma Unit, Department of Onco-Hematology, IRCCS Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy.
  • Corradini P; Immuno-hematology and Transfusion Medicine Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gianni AM; Department of Hemato-Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Gallamini A; Department of Hemato-Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rambaldi A; Division of Hematology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.
Hematol Oncol ; 38(4): 501-508, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32602970
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Tomografia por Emissão de Pósitrons / Quimiocina CCL17 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Tomografia por Emissão de Pósitrons / Quimiocina CCL17 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article